The window period of NEUROGENIN3 during human gestation

Rachel J. Salisbury, Jennifer Blaylock, Andrew A. Berry, Rachel E. Jennings, Ronald De Krijger, Karen Piper Hanley, Neil A. Hanley*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)

Abstract

The basic helix-loop-helix transcription factor, NEUROG3, is critical in causing endocrine commitment from a progenitor cell population in the developing pancreas. In human, NEUROG3 has been detected from 8 weeks postconception (wpc). However, the profile of its production and when it ceases to be detected is unknown. In this study we have defined the profile of NEUROG3 detection in the developing pancreas to give insight into when NEUROG3- dependent endocrine commitment is possible in the human fetus. Immunohistochemistry allowed counting of cells with positively stained nuclei from 7 wpc through to term. mRNA was also isolated from sections of human fetal pancreas and NEUROG3 transcription analyzed by quantitative reverse transcription and polymerase chain reaction. NEUROG3 was detected as expected at 8 wpc. The number of NEUROG3-positive cells increased to peak levels between 10 wpc and 14 wpc. It declined at and after 18 wpc such that it was not detected in human fetal pancreas at 35-41 wpc. Analysis of NEUROG3 transcription corroborated this profile by demonstrating very low levels of transcript at 35-41 wpc, more than 10-fold lower than levels at 12-16 wpc. These data define the appearance, peak and subsequent disappearance of the critical transcription factor, NEUROG3, in human fetal pancreas for the first time. By inference, the window for pancreatic endocrine differentiation via NEUROG3 action opens at 8 wpc and closes between 21 and 35 wpc.

Original languageEnglish
Article numbere954436
JournalIslets
Volume6
Issue number3
DOIs
Publication statusPublished - 1 Aug 2014

Bibliographical note

Funding Information:
This work was supported by the Wellcome Trust (NAH, WT088566MA, Senior Fellowship in Clinical Science; and WT097820MF, Institutional Strategic Support Fund), the Medical Research Council (RJS, PhD student, and REJ, clinical research training fellow) and the Manchester Biomedical Research Centre.

Publisher Copyright:
© 2014 Taylor & Francis Group, LLC.

Keywords

  • Development
  • Endocrine
  • Fetal
  • Human
  • Neurogenin-3 (NEUROG3)
  • Pancreas
  • Sex-determining region Y-box 9 (SOX9)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'The window period of NEUROGENIN3 during human gestation'. Together they form a unique fingerprint.

Cite this